JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Aecom
ACM
$8.62B
| $10.8M | ﹤0.01% |
291,963
+59,650
| +26% | +$2.17M |
|
|
BELFB
1977
Bel Fuse Inc Class B
BELFB
$4.19B
| $10.8M | ﹤0.01% |
430,742
-24,025
| -5% | -$688K |
|
1978
OraSure Technologies
OSUR
$268M
| $10.8M | ﹤0.01% |
574,943
+5,414
| +1% | +$98.1K |
|
1979
Sumitomo Mitsui Financial
SMFG
$160B
| $10.8M | ﹤0.01% |
1,244,119
+21,214
| +2% | +$172K |
|
1980
TriNet
TNET
$3.06B
| $10.8M | ﹤0.01% |
243,830
-257,100
| -51% | -$10.3M |
|
1981
Sun Life Financial
SLF
$44.6B
| $10.8M | ﹤0.01% |
261,884
+24,810
| +10% | +$989K |
|
1982
Puma Biotechnology
PBYI
$453M
| $10.8M | ﹤0.01% |
109,039
+108,333
| +15,345% | +$12.1M |
|
1983
ICF International
ICFI
$1.62B
| $10.8M | ﹤0.01% |
205,236
+6,714
| +3% | +$362K |
|
|
SYNH
1984
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $10.8M | ﹤0.01% |
246,624
-133,520
| -35% | -$6.24M |
|
|
WDR
1985
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $10.7M | ﹤0.01% |
480,943
+233,304
| +94% | +$4.75M |
|
1986
Kelly Services Class A
KELYA
$536M
| $10.7M | ﹤0.01% |
393,970
+14,916
| +4% | +$412K |
|
1987
First Financial Bankshares
FFIN
$4.99B
| $10.7M | ﹤0.01% |
476,322
+152,980
| +47% | +$3.48M |
|
|
WPG
1988
DELISTED
Washington Prime Group Inc.
WPG
| $10.7M | ﹤0.01% |
167,256
+6,834
| +4% | +$464K |
|
1989
B&G Foods
BGS
$277M
| $10.7M | ﹤0.01% |
304,551
+288,846
| +1,839% | +$9.89M |
|
1990
CALL
Goldman Sachs
GS
$301B
| $10.7M | ﹤0.01% |
41,900
-51,800
| -55% | -$12.7M |
|
1991
Powell Industries
POWL
$7.59B
| $10.7M | ﹤0.01% |
1,117,635
+44,109
| +4% | +$422K |
|
1992
Bio-Rad Laboratories Class A
BIO
$9.53B
| $10.6M | ﹤0.01% |
44,599
+13,744
| +45% | +$3.33M |
|
1993
Medifast
MED
$130M
| $10.6M | ﹤0.01% |
152,468
-6,345
| -4% | -$421K |
|
1994
CALL
Adobe
ADBE
$105B
| $10.6M | ﹤0.01% |
60,700
-5,300
| -8% | -$912K |
|
1995
Signet Jewelers
SIG
$3.68B
| $10.6M | ﹤0.01% |
187,882
-163,762
| -47% | -$10M |
|
1996
WisdomTree
WT
$3.33B
| $10.6M | ﹤0.01% |
845,656
+80,261
| +10% | +$921K |
|
|
CNR
1997
Core Natural Resources Inc
CNR
$4.65B
| $10.6M | ﹤0.01% |
+268,245
| New | +$7.83M |
|
|
CMD
1998
DELISTED
Cantel Medical Corporation
CMD
| $10.6M | ﹤0.01% |
102,938
+65,458
| +175% | +$6.52M |
|
1999
PUT
Philip Morris
PM
$290B
| $10.6M | ﹤0.01% |
100,000
| – | – |
|
|
MAG
2000
DELISTED
MAG Silver
MAG
| $10.6M | ﹤0.01% |
853,631
-89,614
| -10% | -$1.01M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.